Elaine C Sarkin Jaffe MD

PubMed

• Testicular follicular lymphoma: let me count the ways.
  Elaine S Jaffe, Leticia Quintanilla-Martinez
  Blood Advances. 2025-02-25
• Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas.
  Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Sanjal Desai
  Leukemia & Lymphoma. 2025-02-03
• Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach.
  Catalina Amador, Dennis D Weisenburger, Ana Gomez, Alyssa Bouska, Ahmad Alshomrani
  Modern Pathology. 2025-02-01

Abstracts/Posters

• Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Anal...
  Elaine S. Jaffe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...
  Elaine S. Jaffe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR
  Elaine S. Jaffe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas
  Elaine S. Jaffe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all